These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28361159)

  • 1. Evaluation of Adjusted and Unadjusted Indirect Comparison Methods in Benefit Assessment. A Simulation Study for Time-to-event Endpoints.
    Kühnast S; Schiffner-Rohe J; Rahnenführer J; Leverkus F
    Methods Inf Med; 2017 May; 56(3):261-267. PubMed ID: 28361159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Methods for Estimating Therapy Effects by Indirect Comparisons: A Simulation Study.
    Weber D; Jensen K; Kieser M
    Med Decis Making; 2020 Jul; 40(5):644-654. PubMed ID: 32659160
    [No Abstract]   [Full Text] [Related]  

  • 3. Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common Comparator.
    Petto H; Kadziola Z; Brnabic A; Saure D; Belger M
    Value Health; 2019 Jan; 22(1):85-91. PubMed ID: 30661638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for population adjustment with limited access to individual patient data: A review and simulation study.
    Remiro-Azócar A; Heath A; Baio G
    Res Synth Methods; 2021 Nov; 12(6):750-775. PubMed ID: 34196111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Model Misspecification in Unanchored Matching-Adjusted Indirect Comparison: Results of a Simulation Study.
    Hatswell AJ; Freemantle N; Baio G
    Value Health; 2020 Jun; 23(6):751-759. PubMed ID: 32540233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison.
    Phillippo DM; Dias S; Ades AE; Welton NJ
    Res Synth Methods; 2020 Jul; 11(4):568-572. PubMed ID: 32395870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research.
    Signorovitch JE; Sikirica V; Erder MH; Xie J; Lu M; Hodgkins PS; Betts KA; Wu EQ
    Value Health; 2012; 15(6):940-7. PubMed ID: 22999145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-stage matching-adjusted indirect comparison.
    Remiro-Azócar A
    BMC Med Res Methodol; 2022 Aug; 22(1):217. PubMed ID: 35941551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.
    Köhler M; Haag S; Biester K; Brockhaus AC; McGauran N; Grouven U; Kölsch H; Seay U; Hörn H; Moritz G; Staeck K; Wieseler B
    BMJ; 2015 Feb; 350():h796. PubMed ID: 25722024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of several matching adjusted indirect comparisons (MAICs) with an application in psoriasis.
    Saure D; Schacht A; Kadziola Z; Brnabic AJM
    Pharm Stat; 2020 Sep; 19(5):532-540. PubMed ID: 32115845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review and shiny application on the matching-adjusted indirect comparison.
    Jiang Z; Cappelleri JC; Gamalo M; Chen Y; Thomas N; Chu H
    Res Synth Methods; 2024 Jul; 15(4):671-686. PubMed ID: 38380799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment-Schedule Matching in Unanchored Indirect Treatment Comparisons of Progression-Free Survival in Cancer Studies.
    Kapetanakis V; Prawitz T; Schlichting M; Ishak KJ; Phatak H; Kearney M; Stevens JW; Benedict A; Bharmal M
    Pharmacoeconomics; 2019 Dec; 37(12):1537-1551. PubMed ID: 31555968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis.
    Samjoo IA; Worthington E; Haltner A; Cameron C; Nicholas R; Dahlke F; Adlard N
    Curr Med Res Opin; 2020 Jul; 36(7):1145-1156. PubMed ID: 32216597
    [No Abstract]   [Full Text] [Related]  

  • 14. How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.
    Kapetanakis V; Prawitz T; Schlichting M; Ishak KJ; Phatak H; Yu T; Bharmal M
    Value Health; 2021 Aug; 24(8):1137-1144. PubMed ID: 34372979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of unanchored matching-adjusted indirect comparison (MAIC) for the evidence synthesis of single-arm trials with time-to-event outcomes.
    Jiang Y; Ni W
    BMC Med Res Methodol; 2020 Sep; 20(1):241. PubMed ID: 32993519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing unanchored simulated treatment comparisons: A novel implementation and simulation study.
    Ren S; Ren S; Welton NJ; Strong M
    Res Synth Methods; 2024 Jul; 15(4):657-670. PubMed ID: 38590103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early benefit assessment of new drugs in Germany - results from 2011 to 2012.
    Hörn H; Nink K; McGauran N; Wieseler B
    Health Policy; 2014 Jun; 116(2-3):147-53. PubMed ID: 24472328
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.